Contract Pharma Contract Pharma Talks with Jim Donovan of Pfizer CentreOne. Vice President and General Manager of Pfizer CentreOne talks with Ben Locwin about drug development trends and challenges and Pfizer’s lightspeed approach.

LGM Pharma’s chief executive talks industry trends and the company’s continued growth as a provider of tailored API and CDMO services. Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors ...

Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry. View all

Top 20 Pharma and Biopharma Companies As expected, in 2023 sales for pharmaceutical companies making COVID-19 vaccines and treatments, including big names like Pfizer, took a nosedive.

The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

News Releases Former Assets of a cGMP Contract Research Organization – Multi Location Auction. Federal Equipment Company and Proxio Group are collaborating to auction off the former assets of a cGMP Contract Research Organization.

Jan 31, 2024 · Kintara Therapeutics Inc., a biopharmaceutical company investigating REM-001 in an NIH-sponsored and funded open label study in cutaneous metastatic breast cancer, and TuHURA Biosciences, Inc., a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, have entered into a definitive agreement for an all-stock transaction ...

Literature / Brochures Orally-Disintegrating Dosage Forms With Taste Masked Multiparticulates. View our presentation from the Drug Delivery Virtual Event where Adare discusses taste masking strategies, Adare’s Taste-Masking technologies, and dosage forms.

Mar 11, 2024 · The last several years have been tumultuous for the CDMO sector. Some companies benefited from a surge in demand for COVID vaccine and therapeutic manufacturing capacity, while others struggled to maintain supplies of key components and materials, and the drop in COVID-vaccine demand and therapeutic obsolescence due to virus variants have caused further disruption.

Jul 31, 2024 · In 2023, AbbVie experienced the loss of exclusivity (LOE) for Humira, a monoclonal antibody therapeutic that works by targeting TNF-alpha. Humira was granted FDA approval in 2002 for rheumatoid arthritis, but the biologic had since earned additional indications for Crohn’s disease and ulcerative colitis.